US 11833225
Methods and compositions for efficient gene deletion
granted A61KA61K31/5377A61K31/7088
Quick answer
US patent 11833225 (Methods and compositions for efficient gene deletion) held by CRISPR THERAPEUTICS AG expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/5377, A61K31/7088, A61K35/28, A61K38/465